|
|
Article: Vytorin and Zetia fail in heart study
- Article from:
- Deseret News (Salt Lake City)
- Article date:
- March 31, 2008
- Author:
CopyrightCopyright 2008 Deseret News (Salt Lake City). Provided by ProQuest LLC. (Hide copyright information)
|
CHICAGO -- Leading doctors urged a return to older, tried-and-
true treatments for high cholesterol after hearing full results
Sunday of a failed trial of Vytorin and related drug Zetia.
Millions of Americans already take the drug or one of its
components, Zetia. But doctors were stunned to learn that Vytorin
failed to improve heart disease even though it worked as intended to
reduce three key risk factors.
"People need to turn back to statins," said Yale University
cardiologist Dr. Harlan Krumholz, referring to Lipitor, Crestor and
other widely used brands. "We know that statins are good drugs. We
know that they reduce risks."
The study was closely watched because Zetia and Vytorin have ...